FloorBotics, Inc., 2910 Hatley Drive, Austin, TX USA P: +1-512-422-6749, E: info@floorbotics.com

ATTENTION:

FloorBotics™ is looking for a licensing partner who wants to add SaniBot® to their product portfolio and put the robot into production.

FloorBotics, Inc.
2910 Hatley Drive
Austin, Texas USA
+1-512-422-6749
info@floorbotics.com

lab-results-banner-5152023

Lab Results

The results from lab tests on 3 types of bacteria:

  1. MRSA (Methicillin Resistant Staphylococcus aureus) was reduced by 99.95%.
  2. C. Diff (Clostridium difficile) was reduced by 99.4%
  3. VRE (vancomycin-resistant enterococci) was reduced by 88.6%

Research shows that SaniBot® will therefore be effective against these pathogens and about 100 others:

Pathogen Required UV dose, mJ/cm2
Clostridium Difficile (c-diff)

Staphylococcus Aureus

Hepatitis

Escherichia coli (E-coli)

Avian influenza (bird flu)

H1N1 Flu (swine flu)

Influenza

Methicillin Resistant Staphylococcus Aureus (MRSA)

Salmonella typhosa (Typhoid Fever)

Streptococcus hemolyticus

SARS-Coronavirus-2

Ebola

9

8

8

7

7

7

7

7

6

6

5

1

Notes:

SaniBot applies a UVC dose of 8.5 mJ/cm2

Table is primarily from ‘Ultraviolet Germicidal Irradiation Handbook’, Kowalski, 2009